
Informed Decisions.
Better Outcomes.
Participation in clinical trial research by community-based oncology practices is necessary to advance the development of innovative, molecularly-targeted cancer therapies. However, complex trial designs and nuanced biomarker requirements, together with limited access to actionable information, create new challenges for practices that want to bring novel therapeutics to their community via clinical research. Our mission at Genospace is to bridge this gap between clinical research and clinical care through developing technology and services that enable the delivery of personalized medicine at scale.

Clinical Trial Matching & Menu Management
Highly-specific trial matching incorporating clinical-genomic patient data alerts providers of patients eligible for a study at their office currently open to enrollment. Increase accruals for your site with Genospace Trial Match.
EMR-to-EDC
(E2E) Integration
Data captured in your site's source EMR system is automatically transferred to a clinical trial database without any intervention from a data coordinator to trigger the transfer. Save time for your site with Genospace E2E.
Study Feasibility
& Site Selection
Evaluate your site's enrollment potential for a new study opportunity by assessing past enrollment rates, competing trials, and other population measures. Make data-driven assessments with Genospace Feasibility.

Genospace Bridges the gap between Clinical Research and Clinical Care
1 in 5
We reach 1 in 5 patients living with cancer through our affiliated sites.1
500+
More than 500 community oncology clinics and research sites utilize Genospace to support their research programs.
50%
Genospace has facilitated an increase in interventional trial enrollments by more than 50% among research sites utilizing the platform.

Oncologists call routinely to ask for guidance about comprehensive genomic profiling results. Genospace provides real-time actionable information and connects clinicians to our expert team of personalized medicine scientists. Genospace is paving a new way forward in clinical research and clinical care.
- Dr. David Spigel, Chief Scientific Officer, SCRI

Want to Make a Difference?
Join a team where data science, software engineering, and creative design intersect to power precision medicine
